CLAIM #40689 · Medtronic PLC (MDT) · 2025Q4 earnings call · May 21, 2025 · due Apr 30, 2026
“So, thanks for the question. So, first of all, thanks for acknowledging the op profit growth. We did, like I said, 8% in Q4 and the guidance for next year is 7%. And if you take out the diabetes, that's -- that would go 8%.”
Geoff Martha · CEO
PENDING
graded after results covering Apr 30, 2026 are reported
Verify independently
SEC filings for MDT ↗ · Claim quote is verbatim from the 2025Q4 earnings call.